VHCP Management as of Dec. 31, 2015
Portfolio Holdings for VHCP Management
VHCP Management holds 21 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dbv Technologies (DBVTF) | 19.6 | $33M | 464k | 70.11 | |
| Heron Therapeutics (HRTX) | 17.7 | $29M | 1.1M | 26.70 | |
| Gw Pharmaceuticals Plc ads | 13.1 | $22M | 312k | 69.44 | |
| Anacor Pharmaceuticals In | 9.6 | $16M | 141k | 112.97 | |
| Coherus Biosciences (CHRS) | 8.5 | $14M | 611k | 22.96 | |
| Lipocine | 6.6 | $11M | 850k | 12.93 | |
| Avalanche Biotechnologies In | 6.3 | $11M | 1.1M | 9.52 | |
| Flamel Technologies | 3.7 | $6.1M | 500k | 12.21 | |
| Zafgen | 2.1 | $3.4M | 542k | 6.29 | |
| Alcobra | 1.8 | $3.0M | 485k | 6.28 | |
| Akari Therapeutics | 1.4 | $2.3M | 158k | 14.50 | |
| Ocera Therapeutics | 1.3 | $2.2M | 704k | 3.12 | |
| ARCA biopharma | 1.3 | $2.2M | 462k | 4.65 | |
| Global Blood Therapeutics In | 1.2 | $2.0M | 61k | 32.33 | |
| Cynapsus Therapeutics | 1.0 | $1.7M | 110k | 15.45 | |
| Edge Therapeutics | 1.0 | $1.7M | 135k | 12.50 | |
| Ascendis Pharma A S (ASND) | 1.0 | $1.6M | 90k | 18.32 | |
| Cytomx Therapeutics (CTMX) | 0.9 | $1.6M | 75k | 20.87 | |
| Pronai Therapeutics | 0.7 | $1.1M | 75k | 15.04 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $872k | 53k | 16.61 | |
| D Stemline Therapeutics | 0.5 | $855k | 135k | 6.31 |
